Bayer Income from Continuous Operations 2010-2024 | BAYRY

Bayer income from continuous operations for the twelve months ending September 30, 2024 was $-2.957B, a 30.5% decline year-over-year.

  • Bayer annual income from continuous operations for 2023 was $-3.184B, a 172.54% decline from 2022.
  • Bayer annual income from continuous operations for 2022 was $4.389B, a 263.01% increase from 2021.
  • Bayer annual income from continuous operations for 2021 was $1.209B, a 106.8% decline from 2020.

Bayer Income from Continuous Operations 2010-2024 | BAYRY

  • Bayer annual income from continuous operations for 2023 was $-3.184B, a 172.54% decline from 2022.
  • Bayer annual income from continuous operations for 2022 was $4.389B, a 263.01% increase from 2021.
  • Bayer annual income from continuous operations for 2021 was $1.209B, a 106.8% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$759.4B
Novo Nordisk (NVO)$387.1B
Johnson & Johnson (JNJ)$342B
AbbVie (ABBV)$309.5B
Merck (MRK)$251.1B
AstraZeneca (AZN)$207.8B
Novartis AG (NVS)$202.5B
Pfizer (PFE)$151.4B
Sanofi (SNY)$123.7B
Innoviva (INVA)$1.1B